Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sunitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00457743
What this trial is testing

A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Pfizer 36
Testing effectiveness (Phase 2)Study completedNCT01396148
What this trial is testing

Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

Who this might be right for
Gastrointestinal Stromal Tumors
Pfizer 6
Not applicableApproved For MarketingNCT00130897
What this trial is testing

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00866320
What this trial is testing

Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center 49
Testing effectiveness (Phase 2)UnknownNCT02398552
What this trial is testing

A Phase II Trila of Sunitinib Schedule 4/2 vs. Shedule 2/1 as First Line Therapy in Metastatic Renal Cell Carcinoma.

Who this might be right for
Metastatic Renal Cell Carcinoma
Peking University Cancer Hospital & Institute 80
Large-scale testing (Phase 3)Looking for participantsNCT07218926
What this trial is testing

IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Who this might be right for
Gastrointestinal Neoplasms
GlaxoSmithKline 450
Testing effectiveness (Phase 2)Study completedNCT00254540
What this trial is testing

Study of SU011248 in Patients With Advanced Kidney Cancer

Who this might be right for
Carcinoma, Renal Cell
Pfizer 51
Not applicableStudy completedNCT04415697
What this trial is testing

Identification of Predictive Gene Expression Profile of Sunitinib Response in Metastatic Clear Cell Renal Carcinomas

Who this might be right for
Kidney CancerBiomarkersGene Expression
Barretos Cancer Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03463460
What this trial is testing

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

Who this might be right for
Thymic Carcinoma
Dwight Owen 9
Testing effectiveness (Phase 2)Study completedNCT00570882
What this trial is testing

Study of Sunitinib Administered as 4/2 vs. 2/1 Schedule in Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Metastatic Renal Cell Carcinoma
Asan Medical Center 76
Not applicableStudy completedNCT03916458
What this trial is testing

REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

Who this might be right for
Carcinoma, Renal Cell
Pfizer 62
Testing effectiveness (Phase 2)Study completedNCT00886132
What this trial is testing

Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands

Who this might be right for
Adenoid Cystic CarcinomaSalivary Gland Cancer
University Health Network, Toronto 14
Testing effectiveness (Phase 2)Study completedNCT02607332
What this trial is testing

Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 25
Large-scale testing (Phase 3)Ended earlyNCT03729245
What this trial is testing

Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)

Who this might be right for
Renal Cell CarcinomaMetastatic Renal Cell Carcinoma
Nektar Therapeutics 623
Testing effectiveness (Phase 2)Study completedNCT00372775
What this trial is testing

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Who this might be right for
Non-Small Cell Lung Cancer
Pfizer 66
Not applicableStudy completedNCT05363072
What this trial is testing

Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.

Who this might be right for
Renal Cell CancerRenal Cell CarcinomaCancer of Kidney+4 more
Pfizer 1,112
Testing effectiveness (Phase 2)UnknownNCT01389583
What this trial is testing

AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients

Who this might be right for
Gastrointestinal Stromal Tumor
National Health Research Institutes, Taiwan 25
Testing effectiveness (Phase 2)Ended earlyNCT00879619
What this trial is testing

Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer+3 more
John P. Fruehauf 4
Not applicableStudy completedNCT02086695
What this trial is testing

Early Detection of Broken Hearts in Cancer Patients

Who this might be right for
Cardiotoxicity
Mayo Clinic 43
Testing effectiveness (Phase 2)Study completedNCT01147822
What this trial is testing

Pazopanib Versus Sunitinib in the Treatment of Asian Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 367
Next Page